These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1853580)

  • 1. Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus.
    López-Cabrera M; Letovsky J; Hu KQ; Siddiqui A
    Virology; 1991 Aug; 183(2):825-9. PubMed ID: 1853580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
    Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
    J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.
    Choi BH; Park GT; Rho HM
    J Biol Chem; 1999 Jan; 274(5):2858-65. PubMed ID: 9915821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I.
    Garcia AD; Ostapchuk P; Hearing P
    J Virol; 1993 Jul; 67(7):3940-50. PubMed ID: 8389913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer.
    Huan B; Siddiqui A
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9059-63. PubMed ID: 1329088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.
    López-Cabrera M; Letovsky J; Hu KQ; Siddiqui A
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5069-73. PubMed ID: 2367525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of a liver-specific enhancer of the hepatitis B virus.
    Trujillo MA; Letovsky J; Maguire HF; Lopez-Cabrera M; Siddiqui A
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3797-801. PubMed ID: 1902571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer.
    Dikstein R; Faktor O; Shaul Y
    Mol Cell Biol; 1990 Aug; 10(8):4427-30. PubMed ID: 2370872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell.
    Fukai K; Takada S; Yokosuka O; Saisho H; Omata M; Koike K
    Virology; 1997 Sep; 236(2):279-87. PubMed ID: 9325235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.
    Brooks AR; Levy-Wilson B
    Mol Cell Biol; 1992 Mar; 12(3):1134-48. PubMed ID: 1545795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hepatitis B virus enhancer 1 is responsive to human interleukin-6.
    Ohno H; Kaneko S; Kobayashi K; Murakami S
    J Med Virol; 1997 Aug; 52(4):413-8. PubMed ID: 9260690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a transcriptional regulatory factor for human aromatase cytochrome P450 gene expression as nuclear factor interleukin-6 (NF-IL6), a member of the CCAAT/enhancer-binding protein family.
    Toda K; Akira S; Kishimoto T; Sasaki H; Hashimoto K; Yamamoto Y; Sagara Y; Shizuta Y
    Eur J Biochem; 1995 Jul; 231(2):292-9. PubMed ID: 7635140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of nuclear factors to functional domains of the duck hepatitis B virus enhancer.
    Lilienbaum A; Crescenzo-Chaigne B; Sall AA; Pillot J; Elfassi E
    J Virol; 1993 Oct; 67(10):6192-200. PubMed ID: 8371357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha.
    Hwang CS; Mandrup S; MacDougald OA; Geiman DE; Lane MD
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):873-7. PubMed ID: 8570651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors.
    Ott M; Thyagarajan SP; Gupta S
    Eur J Clin Invest; 1997 Nov; 27(11):908-15. PubMed ID: 9395786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor of activated T cells (NFAT1-C) represses the enhancer II and pregenomic promoter (EnII/Cp) of hepatitis B virus (HBV) through its responsive site GGAGA and nullifies the HBx-driven transcriptional activation.
    Lee JH; Rho HM
    IUBMB Life; 2001 Apr; 51(4):255-61. PubMed ID: 11569920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1.
    Gilbert S; Galarneau L; Lamontagne A; Roy S; Bélanger L
    J Virol; 2000 Jun; 74(11):5032-9. PubMed ID: 10799577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors.
    Legraverend C; Antonson P; Flodby P; Xanthopoulos KG
    Nucleic Acids Res; 1993 Apr; 21(8):1735-42. PubMed ID: 8493090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.